178 related articles for article (PubMed ID: 36945983)
1. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
İşgören S; Köroğlu G; Görür GD; Demir H
Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
[TBL] [Abstract][Full Text] [Related]
2. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
3. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
5. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
[TBL] [Abstract][Full Text] [Related]
7. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
10. The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic
Şan H; Alagöz E
Mol Imaging Radionucl Ther; 2022 Oct; 31(3):179-190. PubMed ID: 36268854
[TBL] [Abstract][Full Text] [Related]
11. Axillary Lymph Nodes Hypermetabolism After BNT162b2 mRNA COVID-19 Vaccination in Cancer Patients Undergoing 18F-FDG PET/CT: A Cohort Study.
Bernstine H; Priss M; Anati T; Turko O; Gorenberg M; Steinmetz AP; Groshar D
Clin Nucl Med; 2021 May; 46(5):396-401. PubMed ID: 33782299
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.
Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y
J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188
[TBL] [Abstract][Full Text] [Related]
13. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on
Notohamiprodjo S; Eiber M; Lohrmann C; Weber WA
J Nucl Med; 2022 Nov; 63(11):1673-1676. PubMed ID: 35241484
[TBL] [Abstract][Full Text] [Related]
14. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
16. Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and
Ayati N; Evans S; Zakavi SR; Gruenewald SM
Asia Ocean J Nucl Med Biol; 2023; 11(1):4-12. PubMed ID: 36619184
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT.
Ahmed N; Muzaffar S; Binns C; Ilyas MW; Usmani S
Clin Nucl Med; 2021 May; 46(5):435-436. PubMed ID: 33661193
[TBL] [Abstract][Full Text] [Related]
19. Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.
Quak E; Morel A; Faudemer J; Levy C; Ciappuccini R
Clin Nucl Med; 2022 Mar; 47(3):275-276. PubMed ID: 34661560
[TBL] [Abstract][Full Text] [Related]
20. Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on
Seban RD; Richard C; Nascimento-Leite C; Ghidaglia J; Provost C; Gonin J; Tourneau CL; Romano E; Deleval N; Champion L
J Nucl Med; 2022 Aug; 63(8):1231-1238. PubMed ID: 34857663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]